Clinical Trial Update: N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 trial evaluating a combination of Difluoromethylornithine (DFMO) and celecoxib with cyclophosphamide/topotecan …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Celecoxib (Celecoxib)
• Difluoromethylornithine (DFMO) (difluoromethylornithine)
• Topotecan (topotecan)

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED